Archive | Melanoma News

SUU students pilot Eyes on Cancer skin cancer project

With Utah suffering the highest melanoma rate in the United States, Southern Utah University students are now helping rally a first line of defense: hairdressers who regularly look at people’s scalps, where the deadliest melanomas often form.

Read the full story

Posted in Melanoma News, Patients, Latest News

Dr. Sullivan Discusses Role of Dabrafenib Plus Trametinib in Melanoma

Ryan J. Sullivan, MD, associate director of Melanoma at the Massachusetts General Hospital, discusses the significance of the BRAF/MEK combination dabrafenib (Tafinlar) and trametinib (Mekinist), which was the first BRAF/MEK inhibitor regimen to be approved by the FDA for the treatment of patients with BRAF V600E–positive stage III melanoma following complete resection.

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports

CR With Dabrafenib/Trametinib Linked to Long-Term Survival in BRAF+ Melanoma

Patients with unresectable or metastatic BRAF V600-mutant melanoma who achieve a complete response (CR) to dabrafenib (Tafinlar) plus trametinib (Mekinist) are more likely to have improved survival outcomes at 5 years, according to a pooled analysis of data from the phase III COMBI-d and COMBI-v studies.1

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Melanoma Education is Key to Saving Lives

The incidence of melanoma has increased to the head and neck by more than 50% in children, adolescents and young adults over the past nearly 20 years.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

2019 Events

Calculate your risk of getting melanoma Sunscreen calculator
Map of body for recording areas of skin causing you concern on your body Target Therapy Finder